Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
65.90    1.40 (2.17%)
Bid:
64.50
Ask:
65.80
Spread: 1.30 (2.016%)
Market Cap: £102.55m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Holding(s) in Company

8 Apr 2009 12:19

RNS Number : 3576Q
Macfarlane Group PLC
08 April 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

MACFARLANE GROUP PLC

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

NO

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

YES

An event changing the breakdown of voting rights

NO

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

KIFIN LIMITED

4. Full name of shareholder(s) (if different from 3):

PERSHING NOMINEES LIMITED A/C CCCLT

5. Date of transaction (and date on which the threshold is crossed or reached if different):

07 APRIL 2009

6. Date on which issuer notified:

07 APRIL 2009

7. Threshold(s) that is/are crossed or reached:

3.00%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

0

0

4,004,082

4,004,082

3.48%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

4,004,082

3.48%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:

GUY KEEVIL, CREDO CAPITAL PLC

15. Contact telephone number:

+44 207 968 8421

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWRARKWRSRAR
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20263:30 pmRNSExtension of Share Buyback Programme
12th May 20263:28 pmRNSResult of AGM
12th May 20267:00 amRNSAGM Trading Update
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20262:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSNotice of AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:40 amRNSDirector/PDMR Shareholdings
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:12 pmRNSDirector/PDMR Shareholdings
2nd Mar 20268:26 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSAnnual Results 2025
23rd Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:02 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:01 amRNSNotice of Results & Investor Presentation
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTrading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20258:27 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 202511:57 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.